• Je něco špatně v tomto záznamu ?

Background levels of neomorphic 2-hydroxyglutarate facilitate proliferation of primary fibroblasts

A. Dvořák, J. Zelenka, K. Smolková, L. Vítek, P. JeŽek

. 2017 ; 66 (2) : 293-304. [pub] 20161216

Jazyk angličtina Země Česko

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18011458

Each cell types or tissues contain certain "physiological" levels of R-2-hydroxyglutarate (2HG), as well as enzymes for its synthesis and degradation. 2HG accumulates in certain tumors, possessing heterozygous point mutations of isocitrate dehydrogenases IDH1 (cytosolic) or IDH2 (mitochondrial) and contributes to strengthening their malignancy by inhibiting 2-oxoglutarate-dependent dioxygenases. By blocking histone de-methylation and 5-methyl-cytosine hydroxylation, 2HG maintains cancer cells de-differentiated and promotes their proliferation. However, physiological 2HG formation and formation by non-mutant IDH1/2 in cancer cells were neglected. Consequently, low levels of 2HG might play certain physiological roles. We aimed to elucidate this issue and found that compared to highest 2HG levels in hepatocellular carcinoma HepG2 cells and moderate levels in neuroblastoma SH-SY5Y cells, rat primary fibroblast contained low basal 2HG levels at early passages. These levels increased at late passage and likewise 2HG/2OG ratios dropped without growth factors and enormously increased at hypoxia, reaching levels compared to cancer HepG2 cells. Responses in SH-SY5Y cells were opposite. Moreover, external 2HG supplementation enhanced fibroblast growth. Hence, we conclude that low 2HG levels facilitate cell proliferation in primary fibroblasts, acting via hypoxia-induced factor regulations and epigenetic changes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18011458
003      
CZ-PrNML
005      
20180502083258.0
007      
ta
008      
180405s2017 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933249 $2 doi
035    __
$a (PubMed)27982681
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Dvořák, Aleš $u Department of Mitochondrial Physiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University, Prague, Czech Republic $7 ola2017944921
245    10
$a Background levels of neomorphic 2-hydroxyglutarate facilitate proliferation of primary fibroblasts / $c A. Dvořák, J. Zelenka, K. Smolková, L. Vítek, P. JeŽek
520    9_
$a Each cell types or tissues contain certain "physiological" levels of R-2-hydroxyglutarate (2HG), as well as enzymes for its synthesis and degradation. 2HG accumulates in certain tumors, possessing heterozygous point mutations of isocitrate dehydrogenases IDH1 (cytosolic) or IDH2 (mitochondrial) and contributes to strengthening their malignancy by inhibiting 2-oxoglutarate-dependent dioxygenases. By blocking histone de-methylation and 5-methyl-cytosine hydroxylation, 2HG maintains cancer cells de-differentiated and promotes their proliferation. However, physiological 2HG formation and formation by non-mutant IDH1/2 in cancer cells were neglected. Consequently, low levels of 2HG might play certain physiological roles. We aimed to elucidate this issue and found that compared to highest 2HG levels in hepatocellular carcinoma HepG2 cells and moderate levels in neuroblastoma SH-SY5Y cells, rat primary fibroblast contained low basal 2HG levels at early passages. These levels increased at late passage and likewise 2HG/2OG ratios dropped without growth factors and enormously increased at hypoxia, reaching levels compared to cancer HepG2 cells. Responses in SH-SY5Y cells were opposite. Moreover, external 2HG supplementation enhanced fibroblast growth. Hence, we conclude that low 2HG levels facilitate cell proliferation in primary fibroblasts, acting via hypoxia-induced factor regulations and epigenetic changes.
650    _2
$a zvířata $7 D000818
650    _2
$a proliferace buněk $x fyziologie $7 D049109
650    _2
$a kultivované buňky $7 D002478
650    _2
$a fibroblasty $x cytologie $x fyziologie $7 D005347
650    _2
$a vývojová regulace genové exprese $x fyziologie $7 D018507
650    _2
$a glutaráty $x metabolismus $7 D005977
650    _2
$a buňky Hep G2 $7 D056945
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mutace $7 D009154
650    _2
$a experimentální nádory $x patologie $x patofyziologie $7 D009374
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zelenka, Jaroslav, $d 1980- $7 xx0190812 $u Department of Mitochondrial Physiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic; Department of Biochemistry and Microbiology, Institute of Chemical Technology Prague, Czech Republic
700    1_
$a Smolková, Katarína $7 xx0139595 $u Department of Mitochondrial Physiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Vítek, Libor, $d 1969- $7 xx0035071 $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University, Prague, Czech Republic; Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Ježek, Petr, $d 1945- $7 xx0030581 $u Department of Mitochondrial Physiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, č. 2 (2017), s. 293-304
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27982681 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20180405 $b ABA008
991    __
$a 20180430102245 $b ABA008
999    __
$a ok $b bmc $g 1296237 $s 1008270
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 66 $c 2 $d 293-304 $e 20161216 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20180405

Najít záznam

Citační ukazatele

Možnosti archivace